Publications by authors named "Claire-Marie Serre"

9Publications

A new murine model of osteoblastic/osteolytic lesions from human androgen-resistant prostate cancer.

Authors:
Anaïs Fradet Hélène Sorel Baptiste Depalle Claire Marie Serre Delphine Farlay Andrei Turtoi Akeila Bellahcene Hélène Follet Vincent Castronovo Philippe Clézardin Edith Bonnelye

PLoS One 2013 19;8(9):e75092. Epub 2013 Sep 19.

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité U1033, Lyon, France ; Université de Lyon, Lyon, France.

View Article and Find Full Text PDF
June 2014

Targeting lysophosphatidic acid receptor type 1 with Debio 0719 inhibits spontaneous metastasis dissemination of breast cancer cells independently of cell proliferation and angiogenesis.

Authors:
Marion David Johnny Ribeiro Françoise Descotes Claire-Marie Serre Maryse Barbier Maximilien Murone Philippe Clézardin Olivier Peyruchaud

Int J Oncol 2012 Apr 20;40(4):1133-41. Epub 2011 Dec 20.

INSERM, UMR1033, Université de Lyon, Faculté de Médecine Lyon Est, Lyon, France.

View Article and Find Full Text PDF
April 2012

Cancer cell expression of autotaxin controls bone metastasis formation in mouse through lysophosphatidic acid-dependent activation of osteoclasts.

Authors:
Marion David Estelle Wannecq Françoise Descotes Silvia Jansen Blandine Deux Johnny Ribeiro Claire-Marie Serre Sandra Grès Nathalie Bendriss-Vermare Mathieu Bollen Simone Saez Junken Aoki Jean-Sébastien Saulnier-Blache Philippe Clézardin Olivier Peyruchaud

PLoS One 2010 Mar 17;5(3):e9741. Epub 2010 Mar 17.

INSERM, U664, Lyon, France.

View Article and Find Full Text PDF
March 2010

The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases.

Authors:
Ahmed Boucharaba Claire-Marie Serre Julien Guglielmi Jean-Claude Bordet Philippe Clézardin Olivier Peyruchaud

Proc Natl Acad Sci U S A 2006 Jun 12;103(25):9643-8. Epub 2006 Jun 12.

Institut National de la Santé et de la Recherche Médicale (INSERM) U664, 69372 Lyon, France.

View Article and Find Full Text PDF
June 2006

Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate.

Authors:
Marc Colombel Stéphanie Filleur Pierick Fournier Carole Merle Julien Guglielmi Aurélie Courtin Armelle Degeorges Claire Marie Serre Raymonde Bouvier Philippe Clézardin Florence Cabon

Cancer Res 2005 Jan;65(1):300-8

Institut National de la Sante et de la Recherche Medicale, Research Unit 403, Laënnec School of Medicine, Lyon, France.

View Article and Find Full Text PDF
January 2005

Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer.

Authors:
Ahmed Boucharaba Claire-Marie Serre Sandra Grès Jean Sébastien Saulnier-Blache Jean-Claude Bordet Julien Guglielmi Philippe Clézardin Olivier Peyruchaud

J Clin Invest 2004 Dec;114(12):1714-25

INSERM, U403, 69372 Lyon Cedex 08, France.

View Article and Find Full Text PDF
December 2004

[Does tumor angiogenesis play a role in bone metastatic process?].

Authors:
Olivier Peyruchaud Claire-Marie Serre Roisin NicAmhlaoibh Christine Sveigaard Philippe Clézardin

Rev Med Suisse Romande 2004 Feb;124(2):83-4

INSERM Research Unit 403 Faculté de Médecine Laënnec Rue Guillaume Paradin F-69372 Lyon.

View Article and Find Full Text PDF
February 2004

Angiostatin inhibits bone metastasis formation in nude mice through a direct anti-osteoclastic activity.

Authors:
Olivier Peyruchaud Claire-Marie Serre Roisin NicAmhlaoibh Pierrick Fournier Philippe Clezardin

J Biol Chem 2003 Nov 3;278(46):45826-32. Epub 2003 Sep 3.

INSERM Research Unit 403, Faculté de Médecine Laënnec, 69372 Lyon Cedex 08, France.

View Article and Find Full Text PDF
November 2003

Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone.

Authors:
Isabelle Pécheur Olivier Peyruchaud Claire-Marie Serre Julien Guglielmi Carole Voland Francois Bourre Christiane Margue Martine Cohen-Solal Annie Buffet Nelly Kieffer Philippe Clézardin

FASEB J 2002 Aug 21;16(10):1266-8. Epub 2002 Jun 21.

INSERM Research Unit 403, Faculty of Medicine Laënnec, Lyon, France.

View Article and Find Full Text PDF
August 2002